507 research outputs found

    PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada

    Get PDF

    Assessment of Occupational Noise Exposure Among Groundskeepers in North Carolina Public Universities

    Get PDF
    Grant #5100435 from the National Institute for Occupational Safety and Health (NIOSH) through the North Carolina Occupational Safety and Health Education and Research Cente

    Lessons from the Pivot: Higher Education\u27s Response to the Pandemic

    Get PDF
    This text includes chapters from instructional designers, university faculty and staff, and undergraduate and graduate students, and the text has been divided into three sections to reflect these varied perspectives. Each section begins with research-based perspectives, but also contains more personal narratives at the end. While the context of most of the chapters is the United States, there are also chapters with a Canadian context. It is also important to note that, as of the first half of 2021, the pandemic rages on, and mentions of COVID-19 in the following chapters will be reflective of the state of affairs in North America in the spring and fall of 2020.https://scholar.umw.edu/education_books/1000/thumbnail.jp

    Experimental methods in chemical engineering: Scanning electron microscopy and X-ray ultra-microscopy—SEM and XuM

    Get PDF
    Scanning electron microscopy (SEM) produces images at 500 000 times magnification and better than 1 nm resolution to characterize inorganic and organic solid morphology, surface topography, and crystallography. An electron beam interacts with the material and generates secondary electrons (SE) and backscattered electrons (BSE) that detectors capture. Coupled with X-ray energy-dispersive spectroscopy (X-EDS), SEM-EDS identifies elemental composition. X-ray ultra-microscopy (XuM) traverses particles to identify phase changes and areas of high density and voids without slicing through the solids by microtome. Although SEM instrument capability continuously evolves with higher magnification and better resolution, desktop SEMs are becoming standard in laboratories that require frequent imaging and lower magnification. Hand-held cameras (800–1500×) have the advantage of low cost, ease of use, and better colours. SEM depth of field is better than visible light microscopy, but image stacking software has narrowed the gap between the two. Modern user interfaces mean that today's SEM instruments are easier to operate and data acquisition is faster, but operators must be able to select the right technique for the application (e.g., SE vs. BSE). Furthermore, they must understand how operating parameters like probe current, accelerating voltage, spot-diameter, convergence angle, and working distance compromise sample integrity. The number of articles the Web of Science indexes that mention SEM has grown from 1000 in 1990 to over 40 000 in 2021. A bibliometric map identified four clusters of research: mechanical properties and microstructure; nanoparticles, composites, and graphene; antibacterial and green synthesis; and adsorption and wastewater

    A novel strategy to discover and use climate-adapted germplasm

    Get PDF
    Between 2012 and 2015, 150 researchers, research managers, gene bank managers, extension agents, university professors and staff of non-government organizations from Bhutan, Burkina Faso, Costa Rica, Côte d’Ivoire, Guatemala, Nepal, Rwanda, Uganda, Zambia and Zimbabwe acquired new knowledge and skills about the use of climate and crop modelling tools and data sources including the climate analogue tool introduced through the CGIAR research programme on Climate Change, Agriculture and Food Security (CCAFS). Applying these tools and data to their national context, they assessed the changing needs for national and foreign-sourced plant genetic resources for food and agriculture in the context of climate change adaptation. Research teams are now designing strategies to deploy germplasm that is better adapted to future climate changes and that could contribute to increased food security. They are integrating these strategies into organizational agenda’s that will be implemented with own resources

    Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

    Get PDF
    OBJECTIVE: Niraparib is a poly(ADP-ribose) polymerase (PARP) inhibitor approved for use in heavily pretreated patients and as maintenance treatment in patients with newly-diagnosed or recurrent ovarian cancer following a response to platinum-based chemotherapy. We present long-term safety data for niraparib from the ENGOT-OV16/NOVA trial. METHODS: This multicenter, double-blind, randomized, controlled phase III trial evaluated the efficacy and safety of niraparib for the treatment of recurrent ovarian cancer. Patients were randomly assigned 2:1 to receive either once-daily niraparib 300 mg or placebo. Two independent cohorts were enrolled based on germline BRCA mutation status. The primary endpoint was progression-free survival, reported previously. Long-term safety data were from the most recent data cutoff (September 2017). RESULTS: Overall, 367 patients received niraparib 300 mg once daily. Dose reductions due to TEAEs were highest in month 1 (34%) and declined every month thereafter. Incidence of any-grade and grade ≥ 3 hematologic and symptomatic TEAEs was also highest in month 1 and subsequently declined. Incidence of grade ≥ 3 thrombocytopenia decreased from 28% (month 1) to 9% and 5% (months 2 and 3, respectively), with protocol-directed dose interruptions and/or reductions. Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) were reported in 2 and 6 niraparib-treated patients, respectively, and in 1 placebo patient each. Treatment discontinuations due to TEAEs were <5% in each month and time interval measured. CONCLUSION: These data demonstrate the importance of appropriate dose reduction according to toxicity criteria and support the safe long-term use of niraparib for maintenance treatment in patients with recurrent ovarian cancer. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01847274

    Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides

    Get PDF
    Bacterial cell-surface display systems coupled with quantitative screening methods offer the potential to expand protein engineering capabilities. To more fully exploit this potential, a unique bacterial surface display scaffold was engineered to display peptides more efficiently from the surface exposed C- and N-termini of a circularly permuted outer membrane protein. Using directed evolution, efficient membrane localization of a circularly permuted OmpX (CPX) display scaffold was rescued, thereby improving the presentation of diverse passenger peptides on the cell surface. Random and targeted mutagenesis directed towards linkers joining the native N- and C-termini of OmpX coupled with screening by FACS yielded an enhanced CPX (eCPX) variant which localized to the outer membrane as efficiently as the non-permuted parent. Interestingly, enhancing substitutions coincided with a C-terminal motif conserved in outer membrane proteins. Surface localization of various passenger peptides and mini-proteins was expedited using eCPX relative to that achieved with the parent scaffold. The new variant also permitted simultaneous display and labeling of distinct peptides on structurally adjacent C- and N-termini, thus enabling display level normalization during library screening and the display of bidentate or dimeric peptides. Consequently, the evolved scaffold, eCPX, expands the range of applications for bacterial display. Finally, this approach provides a route to improve the performance of cell-surface display vectors for protein engineering and design
    corecore